Drawing for MEDIQ

USPTO serial 79117093

MEDIQ

Reviewed by CopyMark Law Group

Reg. 4299864Status 404
Filing date
Status date
Registration date
Mar 12, 2013
Examiner
ALLEN, SUSAN EILEEN BI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; cosmetic creams; lip balm, not for medical purposesSECTION 71 - CANCELLED—
030Glucose for culinary purposes; pastilles, not for pharmaceutical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
May 22, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 18, 2019C71TCANCELLED SECTION 71—
Mar 12, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 17, 2017CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 4, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 23, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 5, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 5, 2013FIMPFINAL DISPOSITION PROCESSED—
Jun 12, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 16, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 12, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 25, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 25, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 23, 2012GPNXNOTIFICATION PROCESSED BY IB—
Dec 5, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 5, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 5, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 19, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 16, 2012ALIEASSIGNED TO LIE—
Oct 31, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 11, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 10, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 10, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 7, 2012RFNPREFUSAL PROCESSED BY IB—
Sep 22, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 20, 2012RFRRREFUSAL PROCESSED BY MPU—
Sep 20, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 19, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2012DOCKASSIGNED TO EXAMINER—
Sep 18, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2012LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 14, 2012SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance